Ematologia, Speciale EHA 2024

from Salute e Società · host Marco Caracciolo

1. Approvazione della Commissione Europea per iptacopan come prima monoterapia orale per i pazienti adulti con emoglobinuria parossistica notturna. 2. Isatuximab migliora significativamente la sopravvivenza libera da progressione nel mieloma multiplo di nuova diagnosi non eleggibile al trapianto. 3. Premio alla carriera per la professoressa Maria Domenica Cappellini dell'università di Milano.

Episode metadata supplied by the publisher feed · Published Jun 22, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Ematologia, Speciale EHA 2024

0:00 7:01

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Salute e Società?

This episode is 7 minutes long.

When was this Salute e Società episode published?

This episode was published on June 22, 2024.

Can I download this Salute e Società episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!